Claire Swift

1.1k total citations
10 papers, 126 citations indexed

About

Claire Swift is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Oncology. According to data from OpenAlex, Claire Swift has authored 10 papers receiving a total of 126 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 4 papers in Cancer Research and 3 papers in Oncology. Recurrent topics in Claire Swift's work include Advanced Breast Cancer Therapies (7 papers), Cancer Genomics and Diagnostics (3 papers) and BRCA gene mutations in cancer (2 papers). Claire Swift is often cited by papers focused on Advanced Breast Cancer Therapies (7 papers), Cancer Genomics and Diagnostics (3 papers) and BRCA gene mutations in cancer (2 papers). Claire Swift collaborates with scholars based in United Kingdom, United States and Austria. Claire Swift's co-authors include Isaac García-Murillas, Nicholas C. Turner, Matthew Beaney, William J. Gradishar, Stephen Johnston, Judith M. Bliss, Aman U. Budzar, Martine Piccart, J.F.R. Robertson and Charlotte Fribbens and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research.

In The Last Decade

Claire Swift

10 papers receiving 122 citations

Peers

Countries citing papers authored by Claire Swift

Since Specialization

Citations

This map shows the geographic impact of Claire Swift's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claire Swift with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claire Swift more than expected).

Fields of papers citing papers by Claire Swift

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claire Swift. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claire Swift. The network helps show where Claire Swift may publish in the future.

Co-authorship network of co-authors of Claire Swift

This figure shows the co-authorship network connecting the top 25 collaborators of Claire Swift. A scholar is included among the top collaborators of Claire Swift based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claire Swift. Claire Swift is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

#	Work	Indexed citations
1	Abstract P4-01-02: Results from a dose escalation phase 1b study of palbociclib and avelumab in advanced breast cancer in the PAveMenT Trial 2023 ·Cancer Research ·Alicia Okines, (unknown), (unknown), (unknown), (unknown), Ashutosh Nerurkar, Peter Osin, Claire Swift, (unknown), Nicholas C. Turner	3
2	Abstract OT1-01-01: A randomised phase II trial of palbociclib and fulvestrant vs standard endocrine therapy in patients with ER positive HER2 negative breast cancer and ctDNA detected molecular relapse during adjuvant endocrine therapy (TRAK-ER) 2023 ·Cancer Research ·Nicholas C. Turner, (unknown), Catey Bunce, Marie Robert, Caroline Bailleux, Isaac García-Murillas, Komel Khabra, Iain R. Macpherson, Ciara O’Brien, Alicia Okines, Carlo Palmieri, Peter Schmid, Claire Swift, (unknown), (unknown), Jérôme Lemonnier, (unknown), Fabrice André	3
3	Baseline and longitudinal ctDNA biomarkers in GEICAM/2013-02 (PEARL) trial cohort 2 comparing palbociclib and fulvestrant (PAL + FUL) versus capecitabine (CAPE). 2022 ·Journal of Clinical Oncology ·Javier Pascual, Miguel Martín, Paula Proszek, Miguel Gil‐Gil, (unknown), Christoph Zielinski, Jesús Herránz, Ros Cutts, Manuel Ruíz‐Borrego, Andrew Feber, Eva Ciruelos, Claire Swift, Montserrat Muñoz-Mateu, Begoña Bermejo, Mireia Margelí Vila, Yuan Liu, Isaac García-Murillas, Michael Hubank, Nicholas C. Turner	1
4	Electroencephalographic evidence of unconscious and conscious attentional bias in people with functional gastrointestinal disorders: A pilot study 2021 ·International Journal of Psychophysiology ·Anastasia Ejova, Nicholas A. Badcock, (unknown), Alissa Beath, Claire Swift, Nicholas J. Talley, Gerald Holtmann, Marjorie M. Walker, Michael Jones	2
5	CCNE1 mRNA and cyclin E1 protein expression as predictive biomarkers for efficacy of palbociclib plus fulvestrant versus capecitabine in the phase III PEARL study. 2021 ·Journal of Clinical Oncology ·Javier Pascual, Miguel Gil‐Gil, Christoph Zielinski, Margaret Hills, Manuel Ruíz‐Borrego, Eva Ciruelos, Isaac García-Murillas, Montserrat Muñoz-Mateu, Begoña Bermejo, Claire Swift, Mireia Margelí Vila, A. Antón Torres, (unknown), Laura Murillo, Yuan Liu, Jesús Herránz, Rosalía Caballero, Ángel Guerrero‐Zotano, Nicholas C. Turner, Miguel Martín	2
6	ESR1 Mutations and Overall Survival on Fulvestrant versus Exemestane in Advanced Hormone Receptor–Positive Breast Cancer: A Combined Analysis of the Phase III SoFEA and EFECT Trials 2020 ·Clinical Cancer Research ·Nicholas C. Turner, Claire Swift, Lucy Kilburn, Charlotte Fribbens, Matthew Beaney, Isaac García-Murillas, Aman U. Budzar, J.F.R. Robertson, William J. Gradishar, Martine Piccart, Gaia Schiavon, Judith M. Bliss, Mitch Dowsett, Stephen Johnston, Stephen Chia	100
7	Abstract GS3-07: The genomic landscape of breast cancer based on ctDNA analysis: Data from the plasmaMATCH trial 2020 ·Cancer Research ·Belinda Kingston, Hannah Bye, Michael Hubank, (unknown), Claire Swift, Matthew Beaney, Lucy Kilburn, Sarah Kernaghan, Andrew Wardley, Iain R. Macpherson, Richard D. Baird, Rebecca Roylance, Katie Wilkinson, Isaac García-Murillas, Judith M. Bliss, Nicholas C. Turner, Alistair Ring, (unknown)	3
8	Prognostic and predictive value of ESR1 mutations in postmenopausal metastatic breast cancer (MBC) patients (pts) resistant to aromatase inhibitors (AI), treated with palbociclib (PAL) in combination with endocrine therapy (ET) or capecitabine (CAP) in the PEARL study. 2020 ·Journal of Clinical Oncology ·Miguel Martín, Christoph Zielinski, Manuel Ruíz‐Borrego, Eva Carrasco, Eva Ciruelos, Montserrat Muñoz-Mateu, Begoña Bermejo, Mireia Margelí Vila, Nicholas C. Turner, Maribel Casas, Antonio Antón, (unknown), István Láng, Cynthia Huang Bartlett, María Koehler, N Martin, Massimo Corsaro, Claire Swift, (unknown), Miguel Gil‐Gil	2
9	Abstract PD2-04: Baseline circulating ESR1 mutation analysis in the randomised phase III EFECT study of fulvestrant versus exemestane in advanced hormone receptor positive breast cancer 2019 ·Cancer Research ·Nicholas C. Turner, Claire Swift, Lucy Kilburn, Isaac García-Murillas, S. Johnston, Aman U. Budzar, J.F.R. Robertson, (unknown), M. Piccart, Gaia Schiavon, Stephen Chia	4
10	Microscopic gastrointestinal stromal tumours: a clinical and molecular study of 13 cases 2016 ·Histopathology ·William J. Anderson, Brendan O’Sullivan, (unknown), Claire Swift, Matthew R. Smith, Nayneeta Deshmukh, Philippe Tanière	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact